Mekinist Tablet, Film Coated
Product Images NDC 0078-1105

33 FDA label images from Novartis Pharmaceuticals Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 33 technical images submitted to the FDA as part of the official labeling for Mekinist (NDC 0078-1105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Trametinib Structure-01 (Mekinist 01)

Trametinib Structure-01 (Mekinist 01)
Chemical structure diagram of trametinib, the active ingredient in Mekinist tablets. The diagram shows the molecular structure including rings, atoms, and bonds characteristic of trametinib's chemical composition.*
FDA Label Image

Figure 1. Kaplan-meier Curves Of Investigator-assessed Progression-free Survival (itt Population) In The Metric Study (Mekinist 02)

Figure 1. Kaplan-meier Curves Of Investigator-assessed Progression-free Survival (itt Population) In The Metric Study (Mekinist 02)
A Kaplan-Meier plot showing proportion progression-free over months for Mekinist (trametinib) versus chemotherapy. The graph compares progression-free survival for Mekinist (N=214) with chemotherapy (N=108), including median months progression-free, hazard ratio, and confidence interval.*
FDA Label Image

Figure 2. Kaplan-meier Curves Of Overall Survival In The Combi-d Study (Mekinist 03)

Figure 2. Kaplan-meier Curves Of Overall Survival In The Combi-d Study (Mekinist 03)
A Kaplan-Meier survival curve chart comparing the proportion alive over time in months from randomization between two groups: Tafinlar plus Mekinist (N=211) and Tafinlar plus Placebo (N=212). The chart includes median survival times, hazard ratio, confidence interval, and P value, with a table of numbers at risk across time points below the graph.*
FDA Label Image

Figure 3. Kaplan-meier Curves For Investigator-assessed Relapse-free Survival In Combi-ad In The Adjuvant Treatment Of Melanoma (Mekinist 06)

Figure 3. Kaplan-meier Curves For Investigator-assessed Relapse-free Survival In Combi-ad In The Adjuvant Treatment Of Melanoma (Mekinist 06)
A Kaplan-Meier survival curve chart showing the proportion alive and relapse-free over time in months from randomization, comparing TAFINLAR + MEKINIST combination therapy to Placebo. The chart includes a time axis from 0 to 51 months and a vertical axis representing the proportion alive and relapse-free from 0 to 1. Below the graph, the number of subjects at risk at various time points is listed for both treatment groups.*
FDA Label Image

Figure 4. Kaplan-meier Curves For Progression-free Survival In Study G2201 (lgg Cohort) (Mekinist 09)

Figure 4.	Kaplan-meier Curves For Progression-free Survival In Study G2201 (lgg Cohort) (Mekinist 09)
A Kaplan-Meier survival probability graph comparing treatment outcomes over time (months) for two drug regimens: Dabrafenib + Trametinib and Carboplatin + Vincristine. The y-axis represents probability percentage, while the x-axis shows time in months. The graph includes hazard ratio and median survival data, with patient risk counts shown below the timeline.*
FDA Label Image

Mekinist-ifu-illustrations-1 (Mekinist 11)

Mekinist-ifu-illustrations-1 (Mekinist 11)
An instructional diagram showing components of a Mekinist oral solution kit, including a bottle adapter (already inserted), a bottle with cap containing pre-mixed Mekinist oral solution, a reusable oral syringe, and a note mentioning instructions for use and patient information leaflets (not shown).*
FDA Label Image

Mekinist-ifu-illustrations-2 (Mekinist 12)

Mekinist-ifu-illustrations-2 (Mekinist 12)
An instructional diagram of a syringe showing labeled parts including the tip, dose markings, black stopper, barrel, and plunger. It depicts components relevant to measuring and administering a liquid dose.*
FDA Label Image

Mekinist-ifu-illustrations-3 (Mekinist 14)

FDA Label Image

Mekinist-ifu-illustrations-4 (Mekinist 13)

Mekinist-ifu-illustrations-4 (Mekinist 13)
An instructional illustration showing three oral medication bottles with liquid and air bubbles inside. It highlights the correct and incorrect amounts of air bubbles: 'Large air bubble' in two bottles labeled 'Not Okay' and 'Small air bubbles' in one bottle labeled 'Okay.' Each bottle includes measurement markings up to 5 mL, indicating dosing volume guidance.*
FDA Label Image

Mekinist-ifu-illustrations-5 (Mekinist 15)

Mekinist-ifu-illustrations-5 (Mekinist 15)
An illustration of a syringe with a needle cap, partially filled with liquid. The syringe is shown in a simple black and white line drawing style, focusing on the device alone without any labeling or additional context.*
FDA Label Image

Mekinist-ifu-illustrations-6 (Mekinist 16)

Mekinist-ifu-illustrations-6 (Mekinist 16)
An instructional illustration showing a medication bottle with a child-resistant cap removed and a dose of liquid medicine being drawn into an oral syringe. Arrows indicate the sequence of removing the cap, accessing the liquid inside the bottle, and drawing it into the syringe for oral administration.*
FDA Label Image

Mekinist-ifu-illustrations-7 (Mekinist 17)

Mekinist-ifu-illustrations-7 (Mekinist 17)
An instructional illustration showing a clear bottle with powder at the bottom, labeled "Powder," and an eye symbol indicating observation. Next to it, a similar bottle is filled with an orange liquid, labeled "Solution," also accompanied by an eye symbol. This image depicts the transformation or observation of powder to solution.*
FDA Label Image

Mekinist-ifu-illustrations-8 (Mekinist 18)

Mekinist-ifu-illustrations-8 (Mekinist 18)
An instructional illustration depicting a bottle with a label and a symbol of an eye pointing to the label, suggesting the importance of reading or verifying the label information on the bottle.*
FDA Label Image

Mekinist-ifu-illustrations-9 (Mekinist 19)

Mekinist-ifu-illustrations-9 (Mekinist 19)
An instructional illustration showing proper handling of a medication bottle. It depicts a hand tilting a bottle with arrows indicating to swirl or gently mix the contents. Below, two bottles are shown side-by-side: one with foam and bubbles labeled "Not Okay," and one with a clear liquid labeled "Okay." This emphasizes that the suspension should be mixed properly and appear free of foam before use.*
FDA Label Image

Mekinist-ifu-illustrations-10 (Mekinist 20)

Mekinist-ifu-illustrations-10 (Mekinist 20)
An instructional illustration showing how to open a child-resistant bottle cap by pressing down while turning the cap to the side. The image depicts hands performing the opening action on a plastic bottle.*
FDA Label Image

Mekinist-ifu-illustrations-11 (Mekinist 21)

Mekinist-ifu-illustrations-11 (Mekinist 21)
An instructional diagram showing two pill bottle tops side by side, labeled 'Not Okay' for a bottle without an orange safety seal and 'Okay' for a bottle with an intact orange safety seal. It illustrates proper and improper safety seal status for medication bottles.*
FDA Label Image

Mekinist-ifu-illustrations-12 (Mekinist 22)

Mekinist-ifu-illustrations-12 (Mekinist 22)
Illustration showing a hand holding a syringe with a plunger being pulled back, accompanied by an arrow pointing upward. Below, a close-up image emphasizes the syringe markings, highlighting the 5 mL measurement, and an eye icon indicating the need to visually confirm the volume.*
FDA Label Image

Mekinist-ifu-illustrations-13 (Mekinist 23)

Mekinist-ifu-illustrations-13 (Mekinist 23)
An instructional illustration showing a person using a device with one hand to press downward on a syringe-like tool positioned over a bottle held with the other hand, likely demonstrating how to withdraw or prepare a liquid medication from the bottle.*
FDA Label Image

Mekinist-ifu-illustrations-14 (Mekinist 24)

Mekinist-ifu-illustrations-14 (Mekinist 24)
An instructional illustration showing a person holding an oral medication bottle upside down and pressing a plunger on a syringe or dropper attached to the bottle, indicating the extraction of liquid medication by pressing downward. The liquid medication is shown in orange inside the bottle.*
FDA Label Image

Mekinist-ifu-illustrations-15 (Mekinist 25)

Mekinist-ifu-illustrations-15 (Mekinist 25)
An instructional illustration depicting hands operating a medical device. One hand holds the base while the other hand lifts an orange component upward, indicating a step in device preparation or use.*
FDA Label Image

Mekinist-ifu-illustrations-16 (Mekinist 26)

Mekinist-ifu-illustrations-16 (Mekinist 26)
An instructional diagram showing a syringe with measurement markings from 5 mL to 15 mL and an eye symbol pointing to the 10 mL mark, indicating a visual measurement reference for liquid volume.*
FDA Label Image

Mekinist-ifu-illustrations-17 (Mekinist 27)

Mekinist-ifu-illustrations-17 (Mekinist 27)
An instructional illustration showing a person administering oral medication to a child using a dosing syringe. The syringe is placed in the child's mouth, demonstrating how to deliver liquid medicine accurately by mouth.*
FDA Label Image

Mekinist-ifu-illustrations-18 (Mekinist 28)

Mekinist-ifu-illustrations-18 (Mekinist 28)
An instructional illustration showing an eye symbol pointing to a liquid medication bottle with a measurement marking of 5 mL, indicating attention to dosage or volume measurement.*
FDA Label Image

Mekinist-ifu-illustrations-19 (Mekinist 29)

Mekinist-ifu-illustrations-19 (Mekinist 29)
An instructional line drawing showing a hand opening a child-resistant bottle cap by pressing down and twisting to the side. This illustration demonstrates the correct method to open a safety cap typically found on medication bottles.*
FDA Label Image

Mekinist-ifu-illustrations-20 (Mekinist 30)

Mekinist-ifu-illustrations-20 (Mekinist 30)
An instructional diagram showing a downward-pointing arrow above a button labeled 'GO TO SECTION C.' This graphic likely guides users to proceed to a specific section in a document or interface.*
FDA Label Image

Mekinist-ifu-illustrations-21 (Mekinist 31)

Mekinist-ifu-illustrations-21 (Mekinist 31)
An instructional illustration showing a faucet dispensing water into a cup held by a hand, likely demonstrating a step in medication administration or preparation procedure.*
FDA Label Image

Mekinist-ifu-illustrations-22 (Mekinist 32)

Mekinist-ifu-illustrations-22 (Mekinist 32)
An instructional illustration showing a hand withdrawing liquid into a syringe from a small container or cup. Two orange arrows indicate the direction of the syringe movement, one pointing upward and one pointing downward.*
FDA Label Image

Mekinist-ifu-illustrations-23 (Mekinist 33)

Mekinist-ifu-illustrations-23 (Mekinist 33)
Illustration showing a syringe with a plunger partially extended and an arrow indicating the direction to push the plunger into the syringe barrel.*
FDA Label Image

Mekinist-ifu-illustrations-24 (Mekinist 04)

Mekinist-ifu-illustrations-24 (Mekinist 04)
Mekinist (trametinib) Tablets 0.5 mg film-coated oral tablets package label. The label indicates 30 tablets, Rx only, manufactured by GlaxoSmithKline Manufacturing S.p.A., distributed by Novartis Pharmaceuticals Corporation. Storage instructions include refrigeration at 2°C to 8°C (36°F to 46°F) and warnings about seal integrity and moisture protection.*
FDA Label Image

Mekinist-ifu-illustrations-25 (Mekinist 05)

Mekinist-ifu-illustrations-25 (Mekinist 05)
Mekinist 2 mg trametinib tablets label by Novartis Pharmaceuticals Corporation. The film-coated oral tablets contain trametinib dimethyl sulfoxide equivalent to 2 mg trametinib. The label shows a 30-tablet count, with storage instructions for refrigeration at 2°C to 8°C, and warnings about safety seal, desiccant, and moisture protection. Manufactured by GlaxoSmithKline Manufacturing in Italy, distributed by Novartis, product of Singapore.*
FDA Label Image

Principal Display Panel Ndc 0078-1105-15 Mekinist® (trametinib) Tablets 0.5 mg* Rx Only 30 Tablets Novartis (Mekinist 07)

Principal Display Panel								Ndc 0078-1105-15								Mekinist® (trametinib) Tablets								0.5 mg*								Rx Only								30 Tablets								Novartis (Mekinist 07)
Mekinist 0.5 mg film-coated tablets label by Novartis Pharmaceuticals Corporation. The label notes each tablet contains 0.5635 mg trametinib dimethyl sulfoxide, equivalent to 0.5 mg trametinib, with a quantity of 30 tablets. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F) and warnings about the safety seal and protection from moisture and light. The label includes a barcode and NDC 0078-1105-15.*
FDA Label Image

Principal Display Panel Ndc 0078-1112-15 Mekinist® (trametinib) Tablets 2 mg* Rx Only 30 Tablets Novartis (Mekinist 08)

Principal Display Panel								Ndc 0078-1112-15								Mekinist® (trametinib) Tablets								2 mg*								Rx Only								30 Tablets								Novartis (Mekinist 08)
Mekinist 2 mg film-coated tablets label showing the active ingredient trametinib. The label includes dosage information, manufacturer details (Novartis Pharmaceuticals Corporation, Stein, Switzerland), and storage instructions requiring refrigeration at 2°C to 8°C. The package size is 30 tablets, and the label features the Novartis logo with NDC 0078-1112-15.*
FDA Label Image

Principal Display Panel Ndc 0078-1161-47 Rx Only Mekinist® (trametinib) For Oral Solution 0.05 mg Per mL* 90 mL (when Reconstituted) To Pharmacist: Reconstitute Before Dispensing*. Dispense With The Enclosed Patient Information And Instructions For Use. For Administration By Caregivers Only. Discard Any Unused Solution 35 Days After Reconstitution. Novartis (Mekinist 10)

Principal Display Panel								Ndc 0078-1161-47								Rx Only								Mekinist® (trametinib) For Oral Solution								0.05 mg Per mL*								90 mL (when Reconstituted)								To Pharmacist: Reconstitute Before Dispensing*. Dispense With The Enclosed Patient Information And Instructions For Use.								For Administration By Caregivers Only.								Discard Any Unused Solution 35 Days After Reconstitution.								Novartis (Mekinist 10)
Mekinist (trametinib) oral solution label for 0.05 mg per mL strength in a 90 mL bottle when reconstituted. The label includes instructions for use, storage conditions, and dosage preparation from powder. It is manufactured by Novartis Pharmaceuticals Corporation and indicates prescription-only status with barcodes and lot/control number areas visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.